CY1124773T1 - Τοπικη φαρμακευτικη συνθεση η οποια εμπεριεχει τουλαχιστον αμιτριπτυλινη για τη θεραπευτικη αντιμετωπιση του περιφερικου νευροπαθητικου αλγους - Google Patents
Τοπικη φαρμακευτικη συνθεση η οποια εμπεριεχει τουλαχιστον αμιτριπτυλινη για τη θεραπευτικη αντιμετωπιση του περιφερικου νευροπαθητικου αλγουςInfo
- Publication number
- CY1124773T1 CY1124773T1 CY20211101036T CY211101036T CY1124773T1 CY 1124773 T1 CY1124773 T1 CY 1124773T1 CY 20211101036 T CY20211101036 T CY 20211101036T CY 211101036 T CY211101036 T CY 211101036T CY 1124773 T1 CY1124773 T1 CY 1124773T1
- Authority
- CY
- Cyprus
- Prior art keywords
- amitriptyline
- pharmaceutical composition
- algae
- composition containing
- peripheral neuropathic
- Prior art date
Links
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000836 amitriptyline Drugs 0.000 title abstract 3
- 230000002093 peripheral effect Effects 0.000 title abstract 2
- 241000195493 Cryptophyta Species 0.000 title 1
- 230000002981 neuropathic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σε μια φαρμακευτική σύνθεση η οποία εμπεριέχει από 10 έως 30 % κατά βάρος αμιτριπτυλίνη ή ένα εκ των φαρμακευτικώς αποδεκτών αλάτων και εστέρων αυτής, σε σχέση με το συνολικό βάρος της σύνθεσης, σε αμιτριπτυλίνη, για τη χρήση της στη θεραπευτική αντιμετώπιση του περιφερικού νευροπαθητικού άλγους μετά τη χημειοθεραπεία, με τοπική χορήγηση.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1753577A FR3065371B1 (fr) | 2017-04-25 | 2017-04-25 | Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques |
PCT/EP2018/059948 WO2018197307A1 (fr) | 2017-04-25 | 2018-04-18 | Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques périphériques |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124773T1 true CY1124773T1 (el) | 2022-11-25 |
Family
ID=59070910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211101036T CY1124773T1 (el) | 2017-04-25 | 2021-11-30 | Τοπικη φαρμακευτικη συνθεση η οποια εμπεριεχει τουλαχιστον αμιτριπτυλινη για τη θεραπευτικη αντιμετωπιση του περιφερικου νευροπαθητικου αλγους |
Country Status (22)
Country | Link |
---|---|
US (2) | US20200197326A1 (el) |
EP (1) | EP3615014B1 (el) |
JP (1) | JP7137618B2 (el) |
KR (1) | KR102534078B1 (el) |
CN (2) | CN110730657A (el) |
AU (1) | AU2018257483B2 (el) |
BR (1) | BR112019022295A2 (el) |
CA (1) | CA3060118A1 (el) |
CY (1) | CY1124773T1 (el) |
DK (1) | DK3615014T3 (el) |
EA (1) | EA201992542A1 (el) |
ES (1) | ES2895073T3 (el) |
FR (1) | FR3065371B1 (el) |
HR (1) | HRP20211887T1 (el) |
HU (1) | HUE057063T2 (el) |
IL (1) | IL270127B2 (el) |
LT (1) | LT3615014T (el) |
PL (1) | PL3615014T3 (el) |
PT (1) | PT3615014T (el) |
RS (1) | RS62666B1 (el) |
SI (1) | SI3615014T1 (el) |
WO (1) | WO2018197307A1 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201902579D0 (en) * | 2019-02-26 | 2019-04-10 | Healx Ltd | Treatment |
WO2020188457A1 (en) * | 2019-03-15 | 2020-09-24 | Ftf Pharma Private Limited | Solutions for oral dosage |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
FR3120787B1 (fr) | 2021-03-19 | 2024-04-26 | Algotherapeutix | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline |
FR3123563A1 (fr) * | 2021-06-03 | 2022-12-09 | Algotherapeutix | Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur |
FR3127689B1 (fr) * | 2021-10-01 | 2024-10-04 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques du membre fantôme |
FR3127688B1 (fr) * | 2021-10-01 | 2024-10-04 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques induites par un coronavirus |
CN114028369B (zh) * | 2021-11-22 | 2023-06-13 | 常州市第四制药厂有限公司 | 一种盐酸阿米替林制剂组合物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2315815A1 (en) * | 2000-07-19 | 2002-01-19 | Peter R. Ford | Topical pain relief composition and carrier |
US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
-
2017
- 2017-04-25 FR FR1753577A patent/FR3065371B1/fr active Active
-
2018
- 2018-04-18 US US16/608,783 patent/US20200197326A1/en not_active Abandoned
- 2018-04-18 JP JP2020510149A patent/JP7137618B2/ja active Active
- 2018-04-18 CN CN201880027698.2A patent/CN110730657A/zh active Pending
- 2018-04-18 PL PL18717085T patent/PL3615014T3/pl unknown
- 2018-04-18 PT PT187170857T patent/PT3615014T/pt unknown
- 2018-04-18 WO PCT/EP2018/059948 patent/WO2018197307A1/fr unknown
- 2018-04-18 EA EA201992542A patent/EA201992542A1/ru unknown
- 2018-04-18 DK DK18717085.7T patent/DK3615014T3/da active
- 2018-04-18 EP EP18717085.7A patent/EP3615014B1/fr active Active
- 2018-04-18 HR HRP20211887TT patent/HRP20211887T1/hr unknown
- 2018-04-18 LT LTEPPCT/EP2018/059948T patent/LT3615014T/lt unknown
- 2018-04-18 HU HUE18717085A patent/HUE057063T2/hu unknown
- 2018-04-18 CN CN202410188087.3A patent/CN118141791A/zh active Pending
- 2018-04-18 SI SI201830488T patent/SI3615014T1/sl unknown
- 2018-04-18 BR BR112019022295A patent/BR112019022295A2/pt unknown
- 2018-04-18 ES ES18717085T patent/ES2895073T3/es active Active
- 2018-04-18 RS RS20211509A patent/RS62666B1/sr unknown
- 2018-04-18 AU AU2018257483A patent/AU2018257483B2/en active Active
- 2018-04-18 KR KR1020197031384A patent/KR102534078B1/ko active IP Right Grant
- 2018-04-18 CA CA3060118A patent/CA3060118A1/fr active Pending
-
2019
- 2019-10-23 IL IL270127A patent/IL270127B2/en unknown
-
2021
- 2021-11-30 CY CY20211101036T patent/CY1124773T1/el unknown
-
2023
- 2023-02-17 US US18/170,804 patent/US20230201138A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA3060118A1 (fr) | 2018-11-01 |
EA201992542A1 (ru) | 2020-03-05 |
HUE057063T2 (hu) | 2022-04-28 |
SI3615014T1 (sl) | 2022-01-31 |
RS62666B1 (sr) | 2021-12-31 |
CN110730657A (zh) | 2020-01-24 |
CN118141791A (zh) | 2024-06-07 |
KR20200011931A (ko) | 2020-02-04 |
EP3615014A1 (fr) | 2020-03-04 |
BR112019022295A2 (pt) | 2020-05-19 |
IL270127B1 (en) | 2023-04-01 |
EP3615014B1 (fr) | 2021-10-06 |
JP2020517752A (ja) | 2020-06-18 |
IL270127B2 (en) | 2023-08-01 |
PT3615014T (pt) | 2021-11-23 |
FR3065371B1 (fr) | 2021-05-21 |
AU2018257483B2 (en) | 2023-09-28 |
AU2018257483A1 (en) | 2019-11-07 |
HRP20211887T1 (hr) | 2022-03-04 |
DK3615014T3 (da) | 2021-12-06 |
KR102534078B1 (ko) | 2023-05-18 |
JP7137618B2 (ja) | 2022-09-14 |
FR3065371A1 (fr) | 2018-10-26 |
US20200197326A1 (en) | 2020-06-25 |
US20230201138A1 (en) | 2023-06-29 |
ES2895073T3 (es) | 2022-02-17 |
WO2018197307A1 (fr) | 2018-11-01 |
LT3615014T (lt) | 2021-12-27 |
PL3615014T3 (pl) | 2022-01-31 |
IL270127A (el) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124773T1 (el) | Τοπικη φαρμακευτικη συνθεση η οποια εμπεριεχει τουλαχιστον αμιτριπτυλινη για τη θεραπευτικη αντιμετωπιση του περιφερικου νευροπαθητικου αλγους | |
CY1125290T1 (el) | Εφαρμογη r-κεταμινης και αλατος αυτης ως φαρμακα | |
CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
CY1123571T1 (el) | Βουπροπιονη για τη ρυθμιση των φαρμακευτικων επιπεδων δεξτρομεθορφανης στο πλασμα | |
CY1122566T1 (el) | Παραγωγο 6,7,8,9-tetpaϋδpo-3h-πυραζολo[4,3-f] ισοκινολινης χρησιμο στη θεραπευτικη αντιμετωπιση του καρκινου | |
BR112018015273A2 (pt) | derivados de benzimidazol como moduladores de ror-gama | |
BR112018010018A2 (pt) | moduladores de ror-gama | |
CY1123059T1 (el) | Αναστολη του διαυλου ιοντων παροδικου δυναμικου του υποδοχεα α1 | |
CY1124243T1 (el) | Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1 | |
CY1120452T1 (el) | Παραγωγο αμιδιου πυραζολης | |
BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
CY1121554T1 (el) | Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης | |
BR112019025230A2 (pt) | Anéis 5-5 fundidos como inibidores de c5a | |
EA201691600A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений | |
DOP2016000254A (es) | Formulaciones farmeceuticas de inhibidor de la quinasa pan-raf, procedimientos para su preparacion, y metodos de uso. | |
EA201890532A1 (ru) | Новые аннелированные бензамиды | |
CY1122077T1 (el) | Νεα δακτυλιωμενα φαινοξυακεταμιδια | |
CY1122899T1 (el) | Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη | |
CY1121345T1 (el) | Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης | |
EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
EA201991287A1 (ru) | Твердые фармацевтические композиции на основе тикагрелора для перорального применения | |
CY1125085T1 (el) | Αρωματικα αμιδια καρβοξυλικου οξεος ως ανταγωνιστες υποδοχεα βραδυκινινης β1 | |
NI201600091A (es) | UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS |